Oxilan (Ioxilan Injection) is a contrast media for use in peripheral procedures because of its viscosity. Its reported low viscosity allows it to reach distal vessels. It also has the lowest osmolality of all nonionic monomers in the U.S. Together, these properties facilitate ease of injection, help improve patient comfort and provide visualization and image quality.
Recent figures indicate that nearly 2.5 million peripheral procedures are performed annually. The contrast media has a molecular structure which includes a hydrophobic region to promote molecular aggregation, thereby reducing the osmolality, Guerbet said. This molecular design also features a terminal hydrophilic group, which results in reduced risk of side effects from binding with biological structures. The hydrophilic group also increases the solubility of the molecule.
For more information: www.guerbet-us.com
July 09, 2024 
